8th AIDS Seminar in KUMAMOTO
@@@‘ζ‚W‰ρŒF–{ƒGƒCƒYƒZƒ~ƒi[ƒvƒƒOƒ‰ƒ€

‘@Poster Session


P-1 –εo@˜aΈ ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”Š΄υ–hŒδŠw
Kazuaki Monde, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion incorporated CCR5

P-2
γˆδ@ŒbŽq ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ / Laboratory of Immunology, NIAID, NIH, Bethesda, MD, USA
Keiko Sakai,
Center for AIDS Research, Kumamoto University, Kumamoto, Japan / Laboratory of Immunology, NIAID, NIH, Bethesda, MD, USA
Molecular Analysis of HIV-1-induced CD4+ T-lymphocyte cytopathicity

P-3
ς@‘Χ•γ ‹ž“s‘εŠw‘εŠw‰@ˆγŠwŒ€‹†‰ΘŒŒ‰tEŽξᇓΰ‰Θ
Taisuke Izumi, Graduate School of Medicine, Kyoto University, Kyoto, Japan

MDM2 promotes the ubiquitination and degradation of HIV-1 Vif


P-4
–kŽR@—TŽq
‹ž“s‘εŠwƒEƒCƒ‹ƒXŒ€‹†ŠŠ΄υ•a‘ΤŒ€‹†—Μˆζ
Hiroko Kitayama, Institute for Virus Research, Kyoto University Kyoto, Japan
HIV-1 Vpr inhibits axon formation that leads to impaired repairment of synaptodendritic connections through induction of mitochondrial dysfunction


P-5 ‘εΞ@^‹v ‘εγ‘εŠw”χΆ•¨•aŒ€‹†ŠƒEƒCƒ‹ƒXŠ΄υ§Œδ•ͺ–μ
Masahisa Ohishi, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
A study of the relationship between genomic RNA dimerization and maturation of virus particle in HIV-1


P-6 –Ψ‘Ί@“N–η ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”Š΄υ§ŒδŠw
Tetsuya Kimura, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Correspondence between Structure and function of HIV-1 Env protein


P-7
—V²@Œh‰ξ ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”Š΄υ–hŒδŠw
Keisuke Yusa,
Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Characterization of CCR5 dependent replication of HIV-1V3L#25

P-8 ŽΔ“c@“ρ ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[•a‘Ԑ§Œδ•ͺ–μ
Junji Shibata,
Center for AIDS Research, Kumamoto University, Kumamoto, Japan
The single mutation in V2 domain affects quaternary structure of trimer gp120 and dramatically increases the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralizing antibodies.

P-9
Ό“c@‹g’C
ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[•a‘Ԑ§Œδ•ͺ–μ
Yoshitatsu Nishida
, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Broad neutralization against the HIV-1 subtype B panel of reference strains by@human monoclonal antibodies established from an HIV-1infected long-term non-progressor

P-10
”¨“c@–œ‹IŽq ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[•a‘Ԑ§Œδ•ͺ–μ
Makiko Hatada, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
HIV-1BaL mutants escaping neutralization from a potent neutralizing anti-V3 monoclonal antibody KD-247


P-11
ŽOͺ@–Ύ ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”–ςŠwΆ‰»Šw•ͺ–μ
Akira Mine,
Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4


P-12
“‘Œ΄@Žη ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Mamoru Fujiwara, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Different Ability of Escape Mutant-Specific Cytotoxic T Cells to Suppress Replication of Escape Mutant and Wild-type HIV-1 in New Hosts


P-13
¬ς@а˜a ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Hirokazu Koizumi, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Ability of HIV-1-specific CTL to suppress HIV-1 replication and selection of escape mutants in chronically HIV-1-infected individuals


P-14 –{‰€@ηq ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Chihiro Motozono, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
The capacity of antigenic peptides that dictates antiviral activity of Cytotoxic T Lymphocytes


P-15
‹g•x@—F ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[—\–hŠJ”­•ͺ–μ
Yuka Yoshidomi, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor


P-16
―–μ@dŽχ ‘—§‘Ϋˆγ—ΓƒZƒ“ƒ^[Œ€‹†Š@“οŽ‘«ŽΎŠ³Œ€‹†•”
Shigeki Hoshino, International Medical Center of Japan, Tokyo, Japan
HIV-1 Vpr induced IL-6 production from monocytes / macrophages via IKK, JNK and p38 pathways


P-17
Œυ–؁@—T–η ‘—§Š΄υΗŒ€‹†Š@–Ζ‰u•”‘ζˆκŽΊ
Yu-ya Mitsuki, AIDS Research Center, National Institute of Infectious Diseases, Kumamoto, Japan
Application of DsRed expressing virus for the analysis of HIV-1 transmission from dendritic cells to T cells.


P-18
Ό‰i —Y—Ί ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”–Ζ‰uŽ―•ΚŠw•ͺ–μ
Yusuke Matsunaga,Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Induction of respiratory syncytial virus antigen specific CTL by utilizing TAP1 gene disrupted allogeneic mouse ES cell-derived dendritic cells


P-19
¬μ@—zˆκ ŽR—œ‘εˆγŠw•””畆‰ΘŠw‹³ŽΊ
Yoichi Ogawa, Faculty of medicine, University of Yamanashi, Yamanashi, Japan
Human Langerhans cells express the functional Toll-like receptors at protein levels

P-20 ¬—с@’ΌŽχ ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Naoki Kobayashi, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Induction of HLA-A2-restricted HCMV immunodominant epitope-specific CTLs in HIV-1-infected and -uninfected individuals with 3 HLA-A*02 subtypes

P-21 Nan Zheng ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Nan Zheng, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Characterization of CD4+ T cell Epitopes of HIV-1 Nef protein


P-22 ”ͺ–Ψ“c@—Iˆκ ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Yuichi Yagita, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Selection of viral mutations by Pol283-8-specific CTLs in 2 different HLA class I restrictions


P-23
–{“c@ˆκ‹M ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Kazutaka Honda, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Strong ability of HLA-C*1202-restricted cytotoxic T lymphocytes to suppress HIV-1 replication


P-24
μ“‡@—[‰ΐ ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Yuka Kawashima, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Control of HIV-1 replication by HIV-1-specific CTL in HLA-B*51+ long-term non progressors


P-25
‘Ί‰z@—El ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Hayato Murakoshi, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Identification of HLA-B*4801-restricted HIV-1-specific CD8 T cell epitopes by using overlap peptides


P-26 –I’J@“ΦŽq ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ / ‘—§‘Ϋˆγ—ΓƒZƒ“ƒ^[@ƒGƒCƒYŽ‘—ÁEŒ€‹†ŠJ”­ƒZƒ“ƒ^[
Atsuko Hachiya,
Center for AIDS Research, Kumamoto University, Kumamoto, Japan / AIDS Clinical Center, International Medical Center of Japan, Tokyo, Japan
Amino acid mutation, N348I in the connection subdomain of HIV-1 reverse transcriptase (RT), confers multi-class resistance to nucleoside and nonnucleoside RT inhibitors

P-27
Β–؁@Šw ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”ŒŒ‰t“ΰ‰ΘŠw•ͺ–μ
Manabu Aoki,
Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
TTNTRNS: An amino acid insert near the p17/p24 Gag cleavage site associated with resistance to protease inhibitors


P-28
ŽR“c@—TŽq “Œ‹žˆγ‰ΘŽ•‰Θ‘εŠwΆ‘̍ޗΏHŠwŒ€‹†Š
Yuko Yamada, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan
Development of chemokine receptor CXCR4 antagonists as X4-HIV entry inhibitors


P-29 —Ρ“c@—f‘ ‘—§‘Ϋˆγ—ΓƒZƒ“ƒ^[ ƒGƒCƒYŽ‘—ÁEŒ€‹†ŠJ”­ƒZƒ“ƒ^[@—Տ°Œ€‹†ŠJ”­•”@Ž‘—ΓŠJ”­ŽΊ
Hayashida Tsunefusa, AIDS Clinical Center, International Medical Center of Japan, Tokyo, Japan
Analysis of CYP2B6 genetic polymorphisms related to efavirenz concentrations in Japanese and Zambian.


P-30
•l•@–qŽq ‘—§Š΄υΗŒ€‹†ŠƒGƒCƒYŒ€‹†ƒZƒ“ƒ^[
Makiko Hamatake, AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan
Identification of hexa-peptidic motifs that inhibit the strand transfe activity of HIV-1 integrase pointing a molecular surface which serves as a potent drug target


P-31
“V–μ@«”V ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”ŒŒ‰t“ΰ‰ΘŠw•ͺ–μ
Masayuki Amano, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
A novel bis-tetrahydrofranylurethane-containing nonpeptidic protease inhibitor (PI) GRL-98065 potent against multi-PI-resistant HIV in vitro


P-32
‚±‚€@N”Ž
ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”ŒŒ‰t“ΰ‰ΘŠw•ͺ–μ
Yasuhiro Koh
, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization


P-33
‹ί“‘@FΊ ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Takaaki Kondo, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Unique cytokine secretion in human memory CD8+ T cells expressing chemokine receptor CCR4


P-34 ‚“c@”δ˜CŽu ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Hiroshi Takata
, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
The functional analysis of subsets in human effector CD8+ T cells


P-35 Ό–؁@ˆθe@ ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[ƒEƒCƒ‹ƒX§Œδ•ͺ–μ
Fumichika Matsuki, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Identification of human Th17 cells by using multi-color flowcytric analysis


P-36 Šβ‰i@Žυ^Žq ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[—\–hŠJ”­•ͺ–μ
Sumako Iwanagai, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Proliferation and Differentiation of Human B Cell in NOD/Scid/Jak-3 deficient Mice


P-37
ƒIƒ}[ƒ‹EƒfƒBƒXƒL ŒF–{‘εŠwƒGƒCƒYŠwŒ€‹†ƒZƒ“ƒ^[—\–hŠJ”­•ͺ–μ
Omar Dessouki, Center for AIDS Research, Kumamoto University, Kumamoto, Japan
Characterization of a minor human NK cell sub-population, CD56dimCD16- cells


P-38 ‘O“c@—m• ŒF–{‘εŠw‘εŠw‰@ˆγŠw–ςŠwŒ€‹†•”Š΄υ–hŒδŠw
Yosuke Maeda, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Characterization of human T cell lines resistant to HIV-1

     
 ƒGƒCƒYƒZƒ~ƒi[TOP  
 © 13 Sep.@@@@@@@@@@@@@@@@@@@@@@@ @¨ 14 Sep.